Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Colorcon
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Hepatitis A Vaccine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Hepatitis A Vaccine?

Hepatitis A Vaccine is an investigational drug.

There have been 4 clinical trials for Hepatitis A Vaccine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2011.

The most common disease conditions in clinical trials are HIV Infections, Urinary Bladder Neoplasms, and Colonic Neoplasms. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), MacroGenics, and National Cancer Institute (NCI).

There are thirteen US patents protecting this investigational drug and two hundred and fifty-two international patents.

Recent Clinical Trials for Hepatitis A Vaccine
TitleSponsorPhase
Phase 1 Study of MGD010 in Healthy SubjectsMacroGenicsPhase 1
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had ChemotherapyNational Cancer Institute (NCI)Phase 2
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive PatientsNational Institute of Allergy and Infectious Diseases (NIAID)N/A

See all Hepatitis A Vaccine clinical trials

Clinical Trial Summary for Hepatitis A Vaccine

Top disease conditions for Hepatitis A Vaccine
Top clinical trial sponsors for Hepatitis A Vaccine

See all Hepatitis A Vaccine clinical trials

US Patents for Hepatitis A Vaccine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Hepatitis A Vaccine   Start Trial Cell culture of hepatitis A virus Merck & Co., Inc. (Rayway, NJ)   Start Trial
Hepatitis A Vaccine   Start Trial Liquid formulations for proteinic pharmaceuticals   Start Trial
Hepatitis A Vaccine   Start Trial Cell culture of hepatitis A virus Merck & Co., Inc. (Rahway, NJ)   Start Trial
Hepatitis A Vaccine   Start Trial Chimeric hepatitis A vaccine The United of America as represented by the Department of Health and Human Services (Washington, DC)   Start Trial
Hepatitis A Vaccine   Start Trial Attenuated hepatitis a virus vaccine which grows in MRC-5 cells The United States of America as represented by the Department of Health and Human Services (Washington, DC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Hepatitis A Vaccine

Drugname Country Document Number Estimated Expiration Related US Patent
Hepatitis A Vaccine Australia 5642396 2015-05-16   Start Trial
Hepatitis A Vaccine Canada 2210996 2015-05-16   Start Trial
Hepatitis A Vaccine European Patent Office 0813421 2015-05-16   Start Trial
Hepatitis A Vaccine World Intellectual Property Organization (WIPO) 9636352 2015-05-16   Start Trial
Hepatitis A Vaccine Austria 8409 1999-09-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
AstraZeneca
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.